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Abstract
The Melanocortin (MC) system is one of the crucial neuropeptidergic systems that modulate
energy balance. The roles of endogenous MC and MC-4 receptor (MC4-R) signaling within the
hypothalamus in the control of homeostatic aspects of feeding are well established. Additional
evidence points to a key role for the central MC system in ethanol consumption. Recently, we
have shown that nucleus accumbens (NAc), but not lateral hypothalamic (LH), infusion of a
selective MC4-R agonist decreases ethanol consumption. Given that MC signaling might
contribute to non-homeostatic aspects of feeding within limbic circuits, we assessed here whether
MC4-R signaling within the NAc and the lateral hypothalamus (LH) alters normal ingestive
hedonic and/or aversive responses to ethanol in rats as measured by a taste reactivity test. Adult
male Sprague-Dawley rats were given NAc- or LH- bilateral infusion of the selective MC4-R
agonist cyclo (NH-CH2-CH2-CO-His-D-Phe-Arg-Trp-Glu)-NH2 (0, 0.75 or 1.5 µg/0.5µl/site) and
following 30 min, the animals received 1 ml of ethanol solution (6% w/v) intraoral for 1 minute
and aversive and hedonic behaviors were recorded. We found that NAc-, but not LH-
administration, of a selective MC4-R agonist decreased total duration of hedonic reactions and
significantly increased aversive reactions relative to saline-infused animals which support the
hypothesis that MC signaling within the NAc may contribute to ethanol consumption by
modulating non-homeostatic aspects (palatability) of intake.
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The Melanocortin (MC) system is one of the crucial neuropeptidergic systems that modulate
energy balance. The roles of endogenous MC and MC-4 receptor (MC4-R) signaling within
the hypothalamus in the control of homeostatic aspects of feeding, food selection and body
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weight are well established [1,2]. More recently, pharmacological and genetic studies have
provided additional evidence that MC signaling plays a key role in ethanol consumption.
Intracerebroventricular (i.c.v.) infusion of the non-selective MC3-R/MC4-R agonist
Melanotan-II (MTII) decreased ethanol consumption in C57BL/6J mice [3] and AA rats [4];
i.c.v. infusion of the non-selective MC3-R/MC4-R antagonist Agouti-related protein
(AgRP)-(83–132) disrupted MTII-induced reduction of ethanol consumption [3] and
increased voluntary ethanol consumption in C57BL/6J mice [5]. Furthermore, i.c.v.
administration of the highly selective MC4-R agonist cyclo-(NH-CH2-CH2-CO-His-D-Phe-
Arg-Trp-Glu)-NH2 in C57BL/6J mice significantly decreased voluntary ethanol
consumption and feeding [5]. Consistent with pharmacological studies, genetic deletion of
AgRP blunted ethanol self-administration and binge-like ethanol drinking [6]. Recent work
from our lab has shown that infusion of a selective MC4-R agonist into the ventral tegmental
area (VTA) and the nucleus accumbens (NAc), but not into the lateral hypothalamus (LH),
reduces ethanol and food consumption [7], which lead us to propose that endogenous α-
MSH within limbic regions might regulate non-homeostatic aspects of ethanol consumption
through MC4-R. The present study directly addresses this hypothesis by evaluating whether
NAc- or LH-infusions of a selective MC4-R agonist alter normal ingestive hedonic and/or
aversive responses to ethanol in adult rats. The taste reactivity (TR) test [8] has been
successfully employed to analyze hedonic aspects of ingestive behaviors apart from post-
ingestive effects. To do that, stereotyped mouth, tongue, and body movements are employed
as indicators of the animal’s perceived palatability of the substance [9]. Ingestive responses
are associated with fluid consumption and positive hedonic reactions, while aversive
responses promotes the expulsion of fluid from the oral cavity and are valid indexes of
negative hedonic reactions to the fluid being evaluated [8,10].
Adult male Sprague-Dawley rats (Charles River Laboratories, Spain) weighing 280–300 g at
the beginning of the experiment were housed individually in an environmentally controlled
room (22 °C temperature on a 12:12h light:dark cycle). Standard rodent chow and water
were provided ad libitum throughout the experiments and all the pharmacological
manipulations were conducted at the onset of the dark phase. Behavioral procedures and
pharmacological techniques were in compliance with the animal care guidelines established
by the Spanish Royal Decrees 1025/2005 for reducing animal pain and discomfort and the
protocols were approved by the University of Almería Bioethical Animal Care and Use
Committee.
Rats were anesthetized with equitesin (0.3ml/100g) and atropine (0.04 mg / kg) to prevent
respiratory distress and then implanted with intraoral and intracerebral (NAc- or LH-
directed) cannulas. The intraoral cannula was constructed of PE-100 tubing and was inserted
through the cheek caudal to the eye and then subcutaneously to exit near the intrascapular
area behind the head [11]. A bilateral 26-G cannula (Plastic One Inc., Germany) aimed at
the NAc or LH was implanted using the following stereotaxic coordinates [12]: NAc: 1.7
mm anterior to bregma, 0.8 mm lateral to the midline, and 5.4 mm ventral to the skull
surface; LH: 2.12 mm posterior to bregma, 2.10 mm lateral to the midline and 8 mm ventral
to the skull surface. At the end of experimental procedures, histological verification of
cannula placement was conducted and only animals with correct cannula placement were
used for statistical analysis (Figure 1).
Rats were given a minimum of 10 days to recover following surgery. During this time, oral
cannulas were flushed every other day with distilled water to prevent clogging and body
weight was recorded to ensure proper recover from surgeries. Once the animals recovered
from surgery, the animals were given 24-h free access to two bottles, one containing plain
water and the other containing a solution of ethanol in plain water (6% w/v), for one month
to ensure that ethanol was not a novel stimulus at the TR test day. Food and water were
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available ad libitum. Taste reactivity tests were conducted in a transparent Plexiglas
chamber (24 cm × 26 cm) resting on a clear glass plate. A mirror was mounted beneath the
chamber at a 45° angle to allow viewing of the ventral surface of the animal. The intraoral
infusions were performed at a constant rate of 1 ml/min, via an infusion pump (Harvad
apparatus, USA) connected to the intraoral cannula. Subjects were recorded with a digital
video camera (Sony, DCR-SR37E) placed focusing on the mirror.
Following one month of continued ethanol access, the animals were weighted and
distributed into 3 sub-groups based on baseline ethanol consumption. One hour before the
beginning of the dark phase of the light:dark cycle ethanol, water and food were removed
from the cages. Then, rats were given bilateral site-directed infusion of the selective MC4-R
agonist cyclo(NH-CH2-CH2-CO-His-D-Phe-Arg-Trp-Glu)-NH2 (Phoenix Pharmaceuticals,
Inc., Belmont, CA) dissolved in isotonic saline into the NA or LH, at either 1.5 µg/0.5µl/site
(NAc n = 8; LH n = 10) or 0.75 µg/0.5µl/site (NAc n = 7; LH n = 10) or an identical volume
of isotonic saline, 0.5 µl/site (NAc n = 9; LH n = 10). The doses selected were based on
previous studies demonstrating a significant reduction in food and ethanol drinking
following central infusion of the compound [7]. Site-directed infusions were given manually
over a one minute period with a 1.0 µl Hamilton syringe connected to a 33-G injector
cannula (Plastic One Inc., Germany) that protruded 1 mm when aimed to the NAc and 0.2
mm when aimed to the LH. Then, rats were immediately returned to their home cage for 20
min until they were moved to the taste-reactivity test room.
All rats in the study were habituated to the general testing procedure for 3 consecutive days
prior to the test day. The animals were placed in the test chamber for 10 min and habituated
to the oral presentation of 1 ml of ethanol solution (6% w/v), following similar procedures
on the test day. The day of TR testing, subjects were placed in the test chamber for an
additional 10 min habituation period (without infusion), followed immediately by the test.
During the test day, animals received 1 ml of ethanol solution (6% w/v) for 1 minute in
which taste reactivity behaviors were recorded by a camera. The video files were scored, in
real time and frame by frame, by two raters blind to the treatment conditions (inter-rater
correlations: rs 0.96). Based on previous studies [10, 13], the typical reactions to ethanol
flavor were considered and categorized as either hedonically ingestive or aversive. The
category of ingestive hedonic reactions included “mouthing”, “tongue protrusions” and
“paw licking”. The category of aversive reactions included “snout and facial wiping”, “head
shaking”, “forelimb flailing” and “gaping”. Hedonic reactions were measured as number of
seconds spent displaying the behaviors and the aversive reactions as number of occurrences.
Independent one-way ANOVAs performed on baseline ethanol intake data showed no
statistical significant drug main effect, indicating that all rats exhibited similar ethanol intake
baseline prior to the TR test: NAc-group: [F (2, 21) = 0.37; p = 0.69], (Mean ± SEM saline
group: 2.89 ± 0.29 g/kg/24-h; MC agonist 0.75 µg dose group: 2.57 ± 0.24g/kg/24-h; MC
agonist 1.5 µg dose group 2.46 ± 0.52 g/kg/24-h). LH group [F (2, 28) = 0.06; p = 0.93]
(Mean ± SEM saline group: 2.43 ± 0.37 g/kg/24-h; MC agonist 0.75 µg dose group: 2.38 ±
0.35 g/kg/24-h and MC agonist 1.5 µg dose group: 2.56 ± 0.38 g/kg/24-h). The ANOVAs
performed on taste reactivity data obtained following NAc-infusion of the selective MC4-R
agonist (0.75 or 1.5 µg) or saline revealed a statistically significant drug main effect F (2,
21) = 4.65, p = 0.02] (Figure 2). Additional post hoc Newman Keuls (NK) analysis showed
that both 0.75 and 1.5 µg doses decreased ingestive reactions (time) relative to saline. The
analysis performed for aversive reactions revealed a significant drug main effect [F (2, 21) =
4.14, p = 0.03] and additional NK analysis showed that infusion of 0.75 µg of the MC4-R
agonist significantly increased aversive reactions (total number) relative to saline-treated
rats. Administration of 1.5 µg of the selective MC4-R agonist triggered a mild increase in
aversive reactions, which did not achieve statistical significance compared with saline or the
low dose of the agonist employed. On the other hand, separate ANOVAs performed on taste
Lerma-Cabrera et al. Page 3










reactivity data following LH-infusion of the selective MC4-R agonist (0.75 or 1.5 µg) or
saline clearly show the absence of any statistically significant drug main effect for hedonic
ingestive F (2, 27) = 0.56, p = 0.95] or aversive responses [F (2, 27) = 1.04, p = 0.37],
indicating that LH-infusion of a selective MC4-R agonist did not significantly alter taste
reactivity to ethanol (Figure 3).
The present study directly addressed, for the first time, the role of MC4-R signaling within
the NAc and the LH in ethanol palatability. The main observations obtained here are: 1)
NAc-administration of either 0.75 and 1.5 µg/site of a selective MC4-R agonist decreased
total duration of ingestive reactions; 2) NAc-administration of 0.75 µg/site of a selective
MC4-R agonist significantly increased aversive reactions relative to saline-infused animals,
while the high dose, 1.5 µg/site, elicited a moderate increase which did not attained
statistical significance. 3) LH-administration of the selective MC4-R agonist did not
significantly modify hedonic ingestive or aversive reactions following intraoral alcohol
flushing as measure in the TR test. Because the MC4-R agonist cyclo(NH-CH2-CH2-CO-
His-D-Phe-Arg-Trp-Glu)-NH2 is a highly selective agonist for MC4-R, with 90-fold
selectivity over MC3-R and a 2000-fold selectivity over MC5-R [14], the present data
indicates that endogenous MC signaling within the NAc, but not within the LH, regulates
ethanol palatability via the MC4-R.
The TR procedure has been successfully employed to characterize taste palatability of an
ample range of tastant stimuli [8, 10, 15], including ethanol solutions [10, 16]. In this regard,
it is important to note that our saline-treated rats showed a similar pattern of complex
hedonic ingestive and aversive reactions to ethanol that have previously been reported when
ethanol is administered and is not a novel stimulus [13, 17]. Thus, consistent with available
behavioral and electrophysiological studies, the present observations confirm that, at least in
the gustatory dimension, control rats perceive the taste of ethanol as a complex taste with
pleasant and unpleasant aspects, coinciding with studies showing that ethanol is perceived
by rats as a mixture of sweet and bitter properties [18]. Additionally and according to the
ability of the TR test to detect changes in taste palatability as a result of pharmacological
manipulation, we found here that stimulation of MC4-R signaling in the NAc, but not in LH,
shifted palatability of a 6% w/v ethanol solution to aversive, as evidenced by an increase in
aversive reactions and a decrease in ingestive reactions during the taste reactivity test.
Because taste factors must play an important role in the final decision to ingest or reject a
fluid [8, 15], one interesting implication of the present data, is that changes in ethanol
palatability induced by NAc-infusion of a MC-agonist might negatively influence voluntary
ethanol consumption. It is true that, concurrent with the distinction between wanting and
liking, consumption and palatability are measures that do not necessarily depend on one
another [19, 20]. An increase in the consumption of a tastant may be observed without
changes in palatability [21] and viceversa, changes in the palatability of a substance may not
necessarily be reflected in intake [17]. Nonetheless, a change in ethanol palatability may be
followed by a change in ethanol intake [22]. Therefore, given recent studies providing
pharmacological evidence that NA-infusion, but not LH-infusion, of the selective MC4-R
agonist cyclo(NH-CH2-CH2-CO-His-D-Phe-Arg-Trp-Glu)-NH2) strongly reduces
voluntary ethanol consumption [7], together with the present observations, it is tempting to
propose that MC signaling within limbic regions have a key role in the hedonic aspects of
ethanol consumption. The specific neural mechanisms involved in the modulatory role of
MC signalling within the NAc in ethanol palatability remain unexplored and, based on
present data, we cannot make direct conclusions about such mechanisms. However, some
tentative ideas pointing to the opiate system are discussed next.
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First, there is solid evidence indicating a role for opioid signaling in ethanol palatability [9,
13, 15, 22]. In this regard, human and animal studies have consistently shown that opioid
antagonists decrease and agonists increase, both palatability and consumption of ethanol.
Thus, rats treated with the opioid antagonist naltrexone showed a reduced palatability
(increased aversive responses and reduced ingestive behaviors) [9, 13] and consumption of
ethanol [13, 22]. Additionally, rats treated with DAMGO, a specific mu opioid receptors
agonist, increased positive hedonic reactions and ethanol consumption [15]. Second,
mutually antagonist interactions between MC and opiates have been described in several
anatomical sites [23]. Thus, opiate withdrawal is precipitated by MC agonists, opiate
tolerance is antagonised by MC antagonists [24] and inhibition of MC signaling alleviates
chronic pain [25]. Moreover, administration of opiates to humans suppresses POMC activity
and its derived opiates [24], and endogenous α-MSH levels are reduced in opiate
dependence [22, 23].
In light of the aforementioned studies showing the existence of important MC-opiate
neurobiological interactions, the role of opiates in ethanol palatability and our present data,
that matches previous TR profiles emerging in rats treated with opioids antagonists [9, 22],
one interesting avenue for future research will be to explore the contribution of MC-opiates
interactions within the NAc to the hedonic aspects of ethanol consumption. Further, a
greater understanding of the mechanism of such neuropeptides interactions will allow an
advancement in potential pharmacological combined treatment approaches for alcoholism.
In conclusion, we report here for the first time direct evidence that MC4-R signaling within
the NAc, a limbic region, modulates ethanol palatability while MC4-R signaling within the
LH seems to be unrelated to ethanol palatability. Taking together the present data and
previous studies [7], we propose that MC signaling within the NAc contributes to ethanol
consumption by modulating non-homeostatic aspects (palatability) of intake while in the
LH, MC signalling regulates homeostatic aspects (e.g., the caloric properties of ethanol).
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1. We test the role of MC4-R signaling within the NAc and LH in ethanol
palatability
2. Infusion of the MC4R agonist into the NAc reduced ethanol palatability
3. Infusion of the MC4-R agonist into the NAc increased aversive taste reactions
4. Infusion of the MC4-R agonist into the LH did not alter ethanol palatability
5. MC4-R signaling within the NAc modulates non-homeostatic aspects of ethanol
intake
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Histological reconstruction showing injection sites (black dots) in the NAc (a) and the LH
(b). Sections are labelled according to the distance from Bregma along the rostral–caudal
axis. Adapted from Paxinos & Watson (1998).
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Mean + SEM data showing duration of hedonic reactions (a) and total aversive reactions (b)
in response to oral administration of ethanol 6% w/v during a TR test, following NAc
infusion of the selective MC4-R agonist cyclo(NH-CH2-CH2-CO-His-D-Phe-Arg-Trp-Glu)-
NH2) (0.75 or 1.5 µg) or isotonic saline. Both 0.75 and 1.5 µg doses significantly decreased
duration of hedonic reactions while only administration of 0.75 µg increased total aversive
reactions relative to saline. *P< 0.05.
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Mean + SEM data showing duration of hedonic reactions (a) and total aversive reactions (b)
in response to oral administration of ethanol 6% w/v during a TR test, following NAc
infusion of the selective MC4-R agonist cyclo(NH-CH2-CH2-CO-His-D-Phe-Arg-Trp-Glu)-
NH2) (0.75 or 1.5 µg) or isotonic saline. LH-infusion of a selective of MC4-R agonist did
not significantly alter ethanol palatability.
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